748796-39-6 Usage
Description
5-Chloromethyl-2-(1H-pyrazol-1-yl)pyridine is an organic compound characterized by its white solid appearance. It is a derivative of pyridine with a chloromethyl group at the 5-position and a pyrazol-1-yl group at the 2-position. 5-Chloromethyl-2-(pyrazol-1-yl)pyridine is known for its potential applications in the pharmaceutical industry due to its unique chemical structure and properties.
Uses
Used in Pharmaceutical Industry:
5-Chloromethyl-2-(1H-pyrazol-1-yl)pyridine is used as a pharmaceutical intermediate for the synthesis of various drugs and medicinal compounds. Its chemical structure allows for further functionalization and modification, making it a versatile building block in the development of new pharmaceuticals.
As a pharmaceutical intermediate, 5-Chloromethyl-2-(1H-pyrazol-1-yl)pyridine is utilized for the following reasons:
1. Its unique chemical structure can be modified to create a wide range of drug candidates with different therapeutic properties.
2. The presence of the chloromethyl group provides a reactive site for further chemical reactions, enabling the synthesis of more complex molecules.
3. The pyrazol-1-yl group at the 2-position introduces additional functionality and diversity to the molecule, which can be exploited for the development of novel drugs with improved pharmacological profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 748796-39-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,8,7,9 and 6 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 748796-39:
(8*7)+(7*4)+(6*8)+(5*7)+(4*9)+(3*6)+(2*3)+(1*9)=236
236 % 10 = 6
So 748796-39-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClN3/c10-6-8-2-3-9(11-7-8)13-5-1-4-12-13/h1-5,7H,6H2
748796-39-6Relevant articles and documents
Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
-
Page/Page column 10; 14, (2008/06/13)
The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):
PROCESS FOR THE PREPARATION OF T-11 BICYCLIC ERYTHROMYCIN DERIVATIVES
-
Page/Page column 40-41, (2010/02/13)
The present invention relates to processes and intermediates for the preparation of 6-11 bicyclic erythromycin derivatives. In particular, the presen tinvention relates to processes and intermediates for the preparation of a compound of formula (IX-c).